申请人:SmithKline Corporation
公开号:US04073912A1
公开(公告)日:1978-02-14
Novel piperidylidene derivatives of benzo-fused xanthenes, thioxanthenes and dibenzoxepins administered internally to an animal host, in therapeutically effective amounts, produce antipsychotic activity essentially free of extrapyramidal symptoms.
将新型哌啶基苯并黄色素、硫代黄色素和二苯并氧杂蒽衍生物内部给予动物宿主,在治疗有效剂量下,产生基本不伴随外周神经症状的抗精神病活性。